ADAPTABLE
LIVE

Serial Number

99545628

Owner

IPSEN BIOPHARM LIMITED

Attorney

Makiko Coffland

Filing Date

Dec 12, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ADAPTABLE Trademark

Serial Number: 99545628

ADAPTABLE is a trademark filed by IPSEN BIOPHARM LIMITED on December 12, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

IPSEN BIOPHARM LIMITED (57 trademarks)

ASH ROAD
WREXHAM LL13 9UF , GB

Entity Type: 03

Trademark Details

Filing Date

December 12, 2025

Registration Date

Not Registered

Goods & Services

Downloadable computer software for scientific analysis within the medical field; computer hardware; downloadable data processing computer software; Computer hardware and recorded software systems for data processing

Pharmaceutical preparations for use in the diagnosis, treatment, or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; pharmaceutical preparations for aesthetic and therapeutic use, including for the diagnosis, treatment, or prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for skin care

Custom manufacture of pharmaceuticals

Pharmaceutical compounding services; dispensing of pharmaceuticals; medical services; healthcare services; providing medical information; consultancy and information services relating to pharmaceutical products

Scientific and technological services, namely, scientific research, analysis, testing, and diagnosis for the treatment or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin, skin care; scientific research and development; medical research; design and development of computer hardware and software; product design and development in the fields of pharmaceuticals, cosmetics, and medical devices; pharmaceutical products development; testing of pharmaceuticals; Scientific research in the nature of conducting clinical trials for others; Medical research laboratory services; providing online, non-downloadable software for scientific analysis within the medical field; consultancy and information services relating to the scientific formulation of pharmaceutical products; pharmaceutical research services

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 15, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 15, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
Apr 18, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 12, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 12, 2025 NWOS
NEW APPLICATION ENTERED
Dec 12, 2025 NWAP